fda tirzepatide news The @U.S. Food and Drug Administration (@fda ) has accepted @Sandoz 's applications for review of two generic versions of tirzepatide, the active ingredient in Eli Lilly and Company 's blockbuster drugs tirzepatide update tirzepatide news update

Some product loss during reconstitution and administration is inevitable

Midi Health and Hers both operate telehealth GLP-1 platforms, but they differ meaningfully in clinical depth, medication selection, and support infrastructure

Kimberly Gomer, M.S., R.D., L.D.N is a registered dietitian who specializes in weight loss, diabetes management, and disordered eating

A personalized treatment plan that considers the patients overall health and specific conditions is important

In the Phase 2 obesity trial, heart-rate increases were dose-dependent, peaked around 24 weeks and then declined afterwards

This is the dose associated with the most noticeable results in the long term, but common side effects should be considered and discussed with your healthcare provider before starting any treatment